Locations:
Search IconSearch
August 28, 2017/Digestive/Case Study

Treatment of “Unresectable” Bilobar Liver Metastasis Using a 2-Stage Approach and HAI: A Case Study

Experienced team, innovative treatment

17-DDI-3877-Quintini-CQD-Hero

By Cristiano Quintini, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Presentation

A 42-year-old female was referred to our institution with large right colon cancer and synchronous bilobar liver metastasis (see presenting CT scan of the liver above). A particular challenge was presented by the lesion encasing the three hepatic veins of the liver (see arrows).

Treatment

The patient received three months of perioperative chemotherapy and was scheduled (three months after the initial presentation) for a two-stage hepatectomy and a combined resection of the primary right colon tumor.

The first surgery included a right hemicolectomy with resection of all the left-sided liver lesions. The surgery was uneventful. On postoperative day 6, the patient underwent a right portal vein embolization with the intent to induce hypotrophy of the right hemi liver and the hypertrophy of the left hemi liver. This approach is used to decrease the risks of postresection liver failure.

Six weeks after the first operation, the patient underwent a right hepatectomy. Given her young age and the extent of the disease, the decision was made to place to also place a hepatic artery infusion (HAI) pump to further decrease her likelihood of recurrence. HAI locoregional treatment is an innovative approach that improves survival after liver resection for metastatic colon cancer. This treatment option is only delivered in selected centers around the world.

The remnant left liver lobe with a catheter inside the gastro-duodenal artery for HAI treatment.

The remnant left liver lobe with a catheter inside the gastro-duodenal artery for HAI treatment.

Outcome

One year after the initial presentation, the patient is free of tumor (see scan below) and receiving routine follow-up scans.

Advertisement

CT scan showing the patient free of tumor.

CT scan showing the patient free of tumor.

Advertisement

Related Articles

Dr. Prabhu
June 8, 2026/Digestive/Surgery

Ajita Prabhu, MD, Appointed New Chair of General Surgery

Dr. Prabhu discusses mentorship, collaboration and her vision for the future of the department

Patient speaking with clinician

How Cleveland Clinic’s Gastrointestinal Cancer Program Is Working to Reshape Screening, Care and Outcomes

New program looks to innovative approaches for advancing early detection and multicancer prevention

Illustration of J pouch
May 21, 2026/Digestive/Research

Ulcerative Colitis Patients with Pyoderma Gangrenosum Have Worse Outcomes with J-Pouch Surgery, Study Finds

Patients have a significantly higher risk of developing fistulas and experiencing future Crohn’s-like changes

Dr. Gorgun in operating room
May 20, 2026/Digestive/Research

Cleveland Clinic Colorectal Surgeons Develop a New Standardized Endoscopic Grading System for Rectal Cancer Response and Organ Preservation

Cleveland Clinic researchers developed an objective tool to assess response following total neoadjuvant therapy.

Patient speaking with physicians
May 11, 2026/Digestive/Research

Adherence to Lifestyle Changes Peaks One Month After Bariatric Surgery, Study Finds

Patients may benefit from booster appointments, psychological support

Dr. Aminian in OR
May 7, 2026/Digestive/Research

Metabolic Surgery May Reverse MASH Cirrhosis, Paired Biopsy Study Suggests

Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment

Dr. Regueiro speaking with patient
May 6, 2026/Digestive/Research

Patients With IBD Who Undergo Colon Cancer Surgery Have Higher Blood Clot Risk

Elevated risk persists for more than a year after surgery, plus more insights from the first study to quantify risk specifically for CRC surgery

Pharmacist filling order
May 5, 2026/Digestive/Research

Fenofibrate-UDCA Combination Therapy Safe and Effective for Primary Biliary Cholangitis

Large, retrospective study indicates improved outcomes after one and five years of treatment

Ad